WUXI YAOMING UNITED BIOTECHNOLOGY CO. LTD
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
WuXi XDC Received Multiple Awards from 2025 Extel (previously "Institutional Investor") Ranking in Diverse Categories 2025-05-20 09:44
WuXi XDC Achieved Another Remarkable Year with Extraordinary Business Performance and Financial Results for 2024 2025-03-24 22:45
WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025 2025-03-13 13:54
WuXi XDC and AbTis Announce Strategic Partnership to Advance Next-Generation ADCs 2025-03-11 21:20
WuXi XDC and LigaChem Biosciences Strengthen Partnership with Expanded MOU to Accelerate ADC Development 2025-02-25 18:34
WuXi XDC Named Best CDMO Winner at 2024 World ADC Awards 2024-11-08 11:27
WuXi XDC Reports Strong Business Updates with Superior Financial Results in 1H 2024: Poised for Future Growth 2024-08-20 23:05
WuXi XDC Delivers Outstanding Performance in 2023 with over 110% Year-On-Year Growth for Both Revenue and Adjusted Net Profit and Achieves Significant Corporate Milestones 2024-03-25 21:39
WuXi XDC Enters into Partnership with Multitude Therapeutics and HySlink Therapeutics, Novel Linker-Payload Technology Enabling Clients to Accelerate ADC Discovery and Development 2024-01-31 10:43
WuXi XDC Named Best CDMO Winner at 2023 World ADC Awards 2023-10-20 16:00
1